Spark Therapeutics

LUXTURNA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Spark Therapeutics

Luxturna HCPCS:

J3398

HCPCS Code Descriptor:

Injection, voretigene neparvovec-rzyl, 1 billion vector genomes

Category:

J Code

Luxturna NDCs:

71394-0415-01

Primary Type:

Opthalmic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intraocular

Luxturna CPT Codes:

Potential CPT administration codes for Luxturna can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Luxturna:

LUXTURNA is an Opthalmic drug manufactured by Spark Therapeutics and administered via the Intraocular route of administration. The J Code: J3398 is aligned to the drug LUXTURNA.

ACCESS PRICING AND MORE BY REGISTERING

J3398 Added Date:

January 1, 2019

J3398 Effective Date:

January 1, 2019

J3398 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Luxturna billing and coding information.
Luxturna patient assistance information can be found through the Spark Therapeutics Generation Patient Services at the URL: https://luxturna.com/patient-support/
LUXTURNA prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for LUXTURNA. Please check back in a few weeks.